Holocene Advisors
KURA icon

Holocene Advisors’s Kura Oncology KURA Stock Holding History

Holocene Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-226,895
Closed -$1.98M – 828
2024
Q4 		$1.98M Sell
226,895
-2,462,561
-92% -$35.4M 0.01% 567
2024
Q3 		$52.6M Hold
2,689,456
– – 0.21% 136
2024
Q2 		$55.4M Buy
2,689,456
+251,993
+10% +$5.18M 0.23% 129
2024
Q1 		$52M Hold
2,437,463
– – 0.19% 147
2023
Q4 		$35.1M Hold
2,437,463
– – 0.14% 177
2023
Q3 		$22.2M Hold
2,437,463
– – 0.1% 209
2023
Q2 		$25.8M Hold
2,437,463
– – 0.11% 192
2023
Q1 		$29.8M Sell
2,437,463
-101,142
-4% -$1.26M 0.15% 173
2022
Q4 		$31.5M Sell
2,538,605
-937,500
-27% -$13.6M 0.19% 147
2022
Q3 		$47.5M Buy
3,476,105
+218,809
+7% +$3.38M 0.3% 103
2022
Q2 		$59.7M Buy
3,257,296
+14,488
+0.4% +$208K 0.36% 93
2022
Q1 		$52.1M Buy
3,242,808
+881,977
+37% +$12.7M 0.27% 123
2021
Q4 		$33.1M Sell
2,360,831
-353,593
-13% -$5.73M 0.17% 153
2021
Q3 		$50.8M Buy
2,714,424
+126,642
+5% +$2.39M 0.28% 115
2021
Q2 		$54M Buy
2,587,782
+346,430
+15% +$8.6M 0.3% 114
2021
Q1 		$63.4M Buy
2,241,352
+621,806
+38% +$19.7M 0.4% 77
2020
Q4 		$52.9M Buy
1,619,546
+355,337
+28% +$12.5M 0.33% 108
2020
Q3 		$38.7M Buy
1,264,209
+371,281
+42% +$8.2M 0.29% 106
2020
Q2 		$14.6M Buy
+892,928
New +$12.9M 0.13% 170

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Holocene Advisors's KURA Position: Q1 2025 in Review

Holocene Advisors sold out of Kura Oncology (KURA) in Q1 2025, closing a stake of 226,895 shares — an estimated $1.98M sold.

Holocene Advisors first reported a position in KURA in Q2 2020 and held it in 19 quarters. The position peaked at $63.4M in Q1 2021. 183 funds tracked by Wall St. Rank hold KURA as of Q1 2025.

  • Holocene Advisors reported no remaining Kura Oncology position as of Q1 2025 after selling out during the quarter.
  • Holocene Advisors sold 226,895 Kura Oncology shares in Q1 2025, an estimated $1.98M.
  • Holocene Advisors first reported a position in Kura Oncology in Q2 2020 and held it in 19 quarters.
  • Holocene Advisors's Kura Oncology position peaked at $63.4M in Q1 2021.
  • 183 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2025.

Based on Holocene Advisors's 13F filing for Q1 2025, filed 15 May 2025.